CIK 0001372299
- Non-accelerated filer
- Smaller reporting company
Ocugen, Inc.
Sign in to watch- Ticker
- OCGN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 484-328-4701
- Business address
- 11 GREAT VALLEY PARKWAY, MALVERN, PA, 19355
- Former names
- HISTOGENICS CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,088,801
- in 2 filings, $1.1M under 10b5-1 plans
Net −$1,088,801. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-01-03 | Subramanian Sanjay Chief Financial Officer | Grant or award | +125,534 | 161,125 | ||
| 2022-01-03 | Subramanian Sanjay Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +454,007 | 454,007 | ||
| 2021-12-16 | Subramanian Sanjay Chief Financial Officer | Grant or award · Option(Right toBuy) | +35,560 | 71,120 | ||
| 2021-11-16 | Subramanian Sanjay Chief Financial Officer | Grant or award · Option (Right to Buy) | +35,560 | 35,560 | ||
| 2021-10-26 | Subramanian Sanjay Chief Financial Officer | Sale | −10,000 | $11.07 | $111K | 35,591 |
| 2021-10-15 | Subramanian Sanjay Chief Financial Officer | Exercise or conversion | +7,990 | $2.19 | $17K | 53,581 |
| 2021-10-15 | Subramanian Sanjay Chief Financial Officer | Sale | −7,990 | $9.96 | $80K | 45,591 |
| 2021-10-15 | Subramanian Sanjay Chief Financial Officer | Exercise or conversion · Option (Right to Buy) | −7,990 | 7,990 | ||
| 2021-08-16 | Subramanian Sanjay Chief Financial Officer | Exercise or conversion | +30,000 | $0.34 | $10K | 75,591 |
| 2021-08-16 | Subramanian Sanjay Chief Financial Officer | Sale | −30,000 | $7.22 | $217K | 45,591 |
| 2021-08-16 | Subramanian Sanjay Chief Financial Officer | Exercise or conversion · Option (Right to Buy) | −30,000 | 246,170 | ||
| 2021-07-15 | Subramanian Sanjay Chief Financial Officer | Exercise or conversion | +31,086 | $0.34 | $11K | 76,677 |
| 2021-07-15 | Subramanian Sanjay Chief Financial Officer | Sale | −31,086 | $6.70 | $208K | 45,591 |
| 2021-07-15 | Subramanian Sanjay Chief Financial Officer | Exercise or conversion · Options (Right to Buy) | −31,086 | 276,170 | ||
| 2021-06-15 | Subramanian Sanjay Chief Financial Officer | Exercise or conversion | +31,000 | $0.34 | $11K | 76,591 |
| 2021-06-15 | Subramanian Sanjay Chief Financial Officer | Sale | −31,000 | $7.00 | $217K | 45,591 |
| 2021-06-15 | Subramanian Sanjay Chief Financial Officer | Exercise or conversion · Option (Right to Buy) | −31,000 | 307,256 | ||
| 2021-05-14 | Subramanian Sanjay Chief Financial Officer | Exercise or conversion | +31,000 | $0.34 | $11K | 76,591 |
| 2021-05-14 | Subramanian Sanjay Chief Financial Officer | Sale | −31,000 | $8.18 | $254K | 45,591 |
| 2021-05-14 | Subramanian Sanjay Chief Financial Officer | Exercise or conversion · Option (Right to Buy) | −31,000 | 338,256 |
Page 1 of 2 · 31 trades